yunhap newsA study result showed that elderly people over the age of 60 who received the fourth dose of the COVID-19 vaccine were three times more resistant to severe disease than the third dose.
According to Reuters news on the 23rd (local time), the Israeli Ministry of Health announced that the results of comparing 400,000 people who received the fourth dose and 600,000 people 4 months or more after the third dose of the third dose of the elderly in their 60s and older on the same day revealed this result.
The Ministry of Health also found that elderly people over the age of 60 who received the fourth dose were twice as likely to be infected with COVID-19 as those who received the third dose.
Earlier on the 17th, Sheva Medical Center, Israel’s largest hospital, announced the results of a clinical trial conducted on medical staff at the hospital. Those who received the fourth dose had higher antibody levels than the third dose, but this was not enough to completely prevent the omicron mutation.
Israel started the fourth dose of vaccination for people over the age of 60 from the beginning of this month amid the rapid spread of the Omicron mutation. So far, there have been no deaths due to omicron mutations.
